Hers GLP-1 Alternative Built for Daily Tracking First
MeAgain is the best Hers GLP-1 alternative for GLP-1 users because it combines a stronger daily app, clearer self-pay math, and flat compounded pricing. Hers Weight Loss offers compounded semaglutide and brand-name GLP-1 options through an async telehealth flow, but its recurring compounded semaglutide total reaches $348/month after the first month once the required monthly Hers fee renews alongside the medication line. MeAgain — the GLP-1 tracking app used by 286,000 users with a 4.8-star App Store rating across over 15,000 ratings — pairs $123/month semaglutide with flat tirzepatide pricing and a separate monthly app subscription. MeAgain adds the week-to-week tools Hers does not highlight on its public pages: a weekly prep checklist, a levels view, injection-site rotation tracking, side-effect logging, food logging, and the home-screen widget. MeAgain medication ships in 5–7 days from US-based 503A and 503B pharmacies after a licensed clinician reviews your in-app intake.
Key takeaways
- 1.From month two onward, Hers' recurring compounded semaglutide total is $348, while MeAgain's is $132.99 with the app included. That works out to roughly $215/month less because MeAgain keeps the medication price flat and adds only a small monthly app subscription instead of a much larger Hers fee.
- 2.20 built-in symptoms, 5 food logging methods, a weekly prep checklist, and a weekly levels chart make MeAgain the stronger daily GLP-1 app. Hers includes weight tracking inside a broader telehealth product, but MeAgain gives the week between doses its own tools.
- 3.286,000 users trust MeAgain, and the app holds a 4.8-star App Store rating across over 15,000 ratings. Weight logging is the app's most-used feature, which fits the week-by-week rhythm most GLP-1 users are trying to keep steady.
- 4.Many MeAgain subscribers have installed MeAgain's home-screen widget, which tracks protein, water, fiber, and steps and shifts the Capy's mood when any of them is low. Instead of waiting for the next check-in, you can see how the day is going from your home screen and adjust before the week slips.
- 5.MeAgain pairs flat medication pricing with a monthly app subscription, ships in 5–7 days from US-based 503A and 503B pharmacies, and lets you cancel anytime. The app is the business model, which keeps the self-pay math easier to understand.
MeAgain vs Hers GLP-1: Better Daily App + Clearer Self-Pay Math
Hers Weight Loss is a real telehealth option with compounded semaglutide, brand-name GLP-1 choices, oral options, and an async care flow inside a broader women's health platform. MeAgain is narrower: compounded medication plus a GLP-1 tracking app used by 286,000 users. The recurring cost story is also different. Hers' public pricing adds a monthly Hers fee to medication billed separately, while MeAgain keeps semaglutide at $123/month, tirzepatide flat across doses, and the app on a separate subscription. Hers fits better if you want brand-name or oral choices. MeAgain fits better if you want clearer recurring math and stronger day-to-day support after treatment starts.
| Feature | MeAgain | Hers Weight Loss |
|---|---|---|
| GLP-1 daily tracking app (286K users) | ||
| Lower recurring compounded semaglutide total | ||
| Single monthly app subscription instead of larger platform fee | ||
| Compounded tirzepatide option | ||
| Shot day checklist with prep steps | ||
| Estimated medication levels chart | ||
| Injection site rotation tracking | ||
| Capybara home-screen widget | ||
| Compounded GLP-1 medication access | ||
| Brand-name GLP-1 options | ||
| Oral semaglutide option | ||
| Async clinician review |
What Makes MeAgain a Better Hers GLP-1 Alternative?
01The Daily GLP-1 App Hers Does Not Match
Hers includes weight tracking inside a broader app, but its public experience centers the prescription, delivery, and care messaging. MeAgain is built around what happens after treatment starts. The weekly prep checklist walks you through injection-day setup so the routine feels repeatable from week one. The weekly levels chart shows the rise and decline in simple visual form. Injection-site rotation tracking remembers which side you used last, so you are not guessing on the next dose. Side-effect logging covers 20 built-in symptoms with a 0–10 severity slider plus custom entries. Food logging supports five input styles, including photo AI and voice. The difference is not that Hers lacks an app. The difference is that MeAgain turns the GLP-1 week itself into the product instead of treating tracking as a smaller part of a larger telehealth service.
02Built for the Week Between Doses
MeAgain was designed around the routine GLP-1 users actually manage: a weekly shot, changing appetite, protein and fiber goals, hydration, side effects, and steady progress over months. That focus matters because treatment is a long game, not a one-time order. STEP-1 followed 1,961 adults taking semaglutide for 68 weeks and reported 14.9% mean weight loss. SURMOUNT-1 followed 2,539 adults taking tirzepatide for 72 weeks and reported 20.9%. Those numbers help explain why day-to-day follow-through matters. Hers is a broader women's health brand with weight loss as one part of the menu. MeAgain is narrower, but that narrowness shows up in the actual workflow: shots, symptoms, food, water, weight, and progress in one place instead of spread across memory, notes, and separate apps.
03Clearer Recurring Math, Not Just a Lower Sticker
Hers' public pricing can look simple at first glance because the medication line starts at $199/month. The fuller picture is that compounded semaglutide sits beside a separate monthly Hers fee: $39 for the first month, then $149/month after that. That puts the recurring compounded semaglutide total at $348/month from month two onward. MeAgain keeps compounded semaglutide at a flat monthly price and adds a separate app subscription, for a recurring total of $132.99/month. MeAgain also offers compounded tirzepatide at a flat price, while Hers' tirzepatide path is brand-name only. Hers still has real strengths if you want oral semaglutide or a brand-name option. MeAgain is better for people who want clearer self-pay math and an app subscription that explains where the money goes.
04A Home Screen That Keeps the Routine Visible
Many MeAgain subscribers have installed MeAgain's home-screen widget, and it changes how the app fits into the day. Protein, water, fiber, and steps stay visible from the home screen, with mood shifts based on your protein, water, fiber, and activity. That means the reminder lives where you already look, not only inside a once-a-week check-in. Capy, the in-app AI companion, can help log meals, answer routine questions, and keep the week in one conversation thread. Journey Cards turn progress photos into milestone snapshots tied to dates or weight changes. Hers gives people a broader telehealth platform and more medication formats. MeAgain gives people the daily visual cues and habit loop that make the week easier to manage once medication is already part of life.
Broader Telehealth Menu vs Daily GLP-1 App
Hers and MeAgain solve different parts of the GLP-1 decision. Hers is a larger telehealth brand with women-focused branding, brand-name options, oral semaglutide, and an async care flow wrapped around a separate monthly Hers fee. MeAgain is narrower: compounded semaglutide or compounded tirzepatide, plus a daily tracking app built around the week after treatment starts. That difference matters because GLP-1 treatment is a long stretch, not a single order page. In STEP-1, 1,961 adults taking semaglutide lost 14.9% of body weight at 68 weeks. In SURMOUNT-1, 2,539 adults taking tirzepatide lost 20.9% at 72 weeks. MeAgain tries to support that long stretch with tracking tools for shots, food, side effects, water, and progress instead of leaving the daily routine to memory.
| Factor | Hers Weight Loss | MeAgain |
|---|---|---|
| Medication access | Compounded semaglutide + brand-name GLP-1 options | Compounded semaglutide and tirzepatide |
| Required monthly fee | $39 first month, then $149/mo | Monthly app subscription |
| Compounded semaglutide medication | $199/mo medication line | $123/mo flat |
| Compounded semaglutide total | $238 first month, $348/mo after | $132.99/mo flat |
| Compounded tirzepatide | Not offered | $199/mo flat |
| Oral semaglutide | Yes | No |
| Brand-name GLP-1 options | Yes | No |
| Pharmacy sourcing | 503B outsourcing facility | US-based 503A and 503B |
| Consultation model | Async intake and messaging | Async via in-app intake |
| Daily app experience | Weight tracking inside Hers app | GLP-1-first app, 286K users |
| Shot day checklist | No public tool shown | Yes — step-by-step prep |
| Estimated medication levels | No public tool shown | Yes — weekly chart |
| Side-effect tracking | No public tool shown | Yes — 20 built-in symptoms |
| Food logging | Meal plans, no public GLP-1 food log shown | Yes — 5 input methods |
| Home-screen widget | No public tool shown | Yes — Capybara widget |
| App Store rating | Hers app | 4.8 stars, over 15,000 ratings |
We make money from our monthly app subscription. That's it. That is why MeAgain can keep compounded semaglutide and compounded tirzepatide on flat pricing, with any savings as MeAgain grows passed on directly to subscribers. Month-to-month, cancel anytime. Hers builds its weight-loss offer around a separate monthly Hers fee plus medication billed separately, so the recurring compounded semaglutide total reaches $348/month after month one. Hers also offers oral and brand-name GLP-1 options that MeAgain does not, so Hers may fit better if those are your priority. MeAgain is built for people who want a stronger daily GLP-1 app, clearer self-pay math, and zero-markup compounded medication without a second telehealth fee. Whichever medication a licensed clinician chooses, the tracker works for it, and the in-app intake is available inside MeAgain for eligible subscribers.
This content is for informational purposes only and does not constitute medical advice. Pricing information is based on publicly available data as of April 2026 and may change. Always consult your doctor about GLP-1 medications.
Sources
- Wilding JPH et al. — Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1, NEJM 2021, n=1,961)
- Jastreboff AM et al. — Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539)
- FDA — Compounded Drug Products: Section 503A and 503B Pharmacies
- FDA — Medications Containing Semaglutide for Type 2 Diabetes and Weight Loss
- FDA — Tirzepatide Drug Information (FDA Drugs@FDA database)
- Hers Weight Loss Program Pricing
What Are Real Users Saying About This Hers GLP-1 Alternative?
Why Subscribers Choose MeAgain Over Hers Weight Loss
People comparing Hers and MeAgain are usually deciding whether a broader telehealth platform is enough, or whether they want a stronger app after the prescription starts. As one App Store reviewer (yesi ortiz, March 22, 2026) wrote: “it helps me track and makes me feel like I have a companion on this journey” That is the gap MeAgain tries to fill: one place for your weekly prep, symptoms, food, water, and progress instead of relying on a separate monthly fee and your own memory between doses.
Hers offers brand-name options, oral semaglutide, and a broader women's health platform. MeAgain offers a focused daily GLP-1 app with prep workflow, side-effect logging, food logging, the home-screen widget, and optional self-pay medication access in the same place. If you want the stronger app once treatment starts, that is the tradeoff.
What Our Users Say
“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”
Hers GLP-1 Alternative - FAQs
Choose MeAgain if you want the daily app to be the main product, not just the prescription. Hers is a real telehealth option with women-focused branding, brand-name GLP-1 choices, and oral semaglutide, but its compounded semaglutide path adds a separate $149 monthly Hers fee after the first month. MeAgain pairs flat medication pricing with a monthly app subscription and a GLP-1-first routine: weekly prep, a levels chart, injection-site rotation tracking, side-effect logging across 20 built-in symptoms, five food logging methods, and the home-screen widget. Hers can make sense if you want the broader telehealth menu. MeAgain is the stronger Hers alternative if you want clearer recurring costs and an app you will keep opening between shots, meals, and weigh-ins.
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.